Patent · US Active

Recombinant probiotic bacteria

US10738315B2 · kind B2 · utility

0Cited by
5References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2015
Grant dateAug 11, 2020
Priority date
Expiry dateNov 2, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.